buyBullishHigh Conviction
Mentioned 7/24/2026
Current ROI
+0.67%TL;DR
General Motors is presented as an incredible value stock trading at just six times forward earnings, printing money, and buying back shares rapidly.
Analysis from 7/24/2026
Creator Profile
Asymmetric Investing by Travis Hoium
YouTube | Stock
47,600 followers
Visit creator profileTracked since June 11, 2026
Return Since June 11, 2026
Creator Strategy-1.76%
Market Index (SPY)+0.16%
Recent Posts
Latest published research
July 24, 2026
1 Incredible Value Stock Hiding in Plain Sight
The creator highlights General Motors (GM) as an undervalued stock, trading at six times forward earnings. The company is described as a "money printing" business with a wide moat in profitable vehicles, strong free cash flow, and a significant share buyback program. Despite not being a high-growth company, GM is expected to show consistent cash flow and has pricing power, making it an attractive value investment.
1 tracked mentions1 linked signals
July 23, 2026
Hims & Hers Stock Pops 13% on Peptide News
Hims & Hers stock saw a significant jump following news that the FDA is considering allowing certain peptides, including BPC 157 and KPV, to be compounded and prescribed. This development could be a substantial tailwind for the company, which is also anticipating a strong earnings report on August 10th. The creator highlights that Hims & Hers is a major position in their portfolio and discusses the company's evolving ecosystem, moving towards integrated data and health insights.
1 tracked mentions1 linked signals
July 23, 2026
Oracle's 60% Stock Crash Explained
The creator explains Oracle's significant stock price decline, attributing it to the company's massive capital expenditure commitments for AI build-outs. These expenditures are expected to outpace operating cash flow, necessitating increased debt or equity issuance, which raises concerns about profitability and shareholder dilution.
1 tracked mentions1 linked signals
Recent Stock Calls
Only high-conviction signal-backed calls appear here, so newer research posts can stay commentary-only.
buyBullishHigh Conviction
Mentioned 7/23/2026
Current ROI
-14.20%TL;DR
Hims & Hers stock is a primary buy due to potential tailwinds from FDA approval of peptides and strong upcoming earnings, with the company being the largest position in the creator's portfolio.
Analysis from 7/24/2026
sell
Mentioned 7/23/2026
Current ROI
+4.21%High-Conviction Portfolio Performance Since June 11, 2026
Total Tickers
3
Success Rate
Locked
Average Return
Locked
Unlock full creator track record
Premium unlocks creator performance analytics, benchmark comparisons, and the historical signal table.
Top winners and losers
Unlock top winners and losers
Premium analytics unlocks the trade outcome breakdown so you can see which calls were the biggest upside and downside contributors.
Ticker Signal History
Unlock ticker signal history
Premium unlocks the creator's full ticker timeline, including bullish, bearish, and research-only events with dates.
Industry Allocation
Unlock sector allocation
Sector concentration is part of the premium creator profile.